Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for chemo- and radioresistant non-Hodgkin's lymphoma cells

被引：0
|
作者：
Roscher, M. [1 ]
Hormann, I. [1 ]
Moreno, J. [2 ]
Leib, O. [2 ]
Marx, S. [2 ]
Miltner, E. [1 ]
Friesen, C. [1 ]
机构：
[1] Univ Ulm, Inst Legal Med, D-89069 Ulm, Germany
[2] Isotope Technol Garching GmbH ITG, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2011年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S213 / S214
页数：2
相关论文
共 50 条
  • [1] Targeted alpha-therapy using [Bi-213] anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells
    Roscher, Mareike
    Hormann, Inis
    Leib, Oliver
    Marx, Sebastian
    Moreno, Josue
    Miltner, Erich
    Friesen, Claudia
    ONCOTARGET, 2013, 4 (02) : 218 - 230
  • [2] BI-213 LABELED ANTI-CD20 MONOCLONAL ANTIBODIES INDUCE APOPTOSIS AND OVERCOME CHEMORESISTANCE IN NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA CELLS
    Friesen, C.
    Roscher, M.
    Hormann, I.
    Morgenstern, A.
    Bruchertseifer, F.
    Apostolidis, C.
    Zenz, Th
    Stilgenbauer, S.
    Miltner, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 307 - 307
  • [3] Targeted alpha therapy using [Bi-213]Substance P overcomes chemo- and radioresistance in glioblastoma and glioblastoma stem cells
    Friesen, C.
    Hormann, I.
    Roscher, M.
    Morgenstern, A.
    Bruchertseifer, F.
    Maecke, H.
    Fulda, S.
    Apostolidis, C.
    Debatin, K. -M.
    Miltner, E.
    ONKOLOGIE, 2010, 33 : 179 - 179
  • [4] Anti-CD20 monoclonal antibody therapy for non-Hodgkin's lymphoma
    White, CA
    Weaver, R
    Royston, I
    MINERVA BIOTECNOLOGICA, 1998, 10 (03) : 108 - 116
  • [5] Endostatin induces tumor stabilization after chemo- or anti-CD20 therapy of high-grade non-Hodgkin's lymphoma (NHL)
    Bertolini, F
    Fusetti, L
    Mancuso, P
    Gobbi, A
    Corsini, C
    Ferrucci, PF
    Martinelli, G
    Pruneri, G
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 66 - 67
  • [6] Targeted anti-cancer therapy using a chimeric anti-CD20 antibody in the treatment of non-Hodgkin's B cell lymphoma
    Anderson, DR
    Varns, C
    IMMUNOLOGY, 1996, 89 : SI112 - SI112
  • [7] Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
    Krasniqi, Ahmet
    D'Huyvetter, Matthias
    Xavier, Catarina
    Van der Jeught, Kevin
    Muyldermans, Serge
    Van der Heyden, Jose
    Lahoutte, Tony
    Tavernier, Jan
    Devoogdt, Nick
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (12) : 2828 - 2839
  • [8] Anti-CD20 monoclonal antibodies as novel treatments for non-Hodgkin's lymphoma
    White, CA
    Larocca, A
    Grillo-López, AJ
    PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (03): : 95 - 101
  • [9] Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma
    Protheroe, A
    Edwards, JCW
    Simmons, A
    Maclennan, K
    Selby, P
    RHEUMATOLOGY, 1999, 38 (11) : 1150 - 1152
  • [10] [Bi-213]-mediated alpha-radioimmunotherapy is a promising therapeutic approach for selectively killing non-Hodgkin's lymphoma cells
    Friesen, C.
    Roscher, M.
    Hormann, I.
    Morgenstern, A.
    Bruchertseifer, F.
    Apostolidis, C.
    Miltner, E.
    ONKOLOGIE, 2010, 33 : 177 - 177
12345